Beyond Air (XAIR) Stock Forecast: StockMap's 2-Week Call
XAIR stock forecast: StockMap's model calls Beyond Air Strong Underperform for the two weeks after the Nov 13 close: it expects XAIR to trail the growth index. It is a call on the gap, not a price target. Right in 2 of 3 two-week windows on XAIR since Sep 24; by chance, a call on the same dates was right 51% of the time.
Beyond Air last closed at $2.13, -3.62% on the session.
Against the IVW growth benchmark the position is -2.71% over the forecast window.
Beyond Air's market cap is $3.54M as of November 13, 2026.
Calls down ↘: the model's call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -75 (behind).
Where XAIR sits: sized by market cap, coloured by the day's move.
The read is built from 15 underlying insights — 0 bullish and 15 bearish.
Agreement across those insights is 100%.
27 daily calls for XAIR so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.
On the fundamentals StockMap ranks Beyond Air in the 1st percentile on return on equity, where 100 is best.
Beyond Air is classified under Health Care / Health Care Equipment & Supplies.
StockMap tracks Beyond Air as the 139th largest of the 142 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.
Across that group the current two-week reads are 74 Neutral, 52 Moderate Underperform, 13 Strong Underperform and 3 Moderate Outperform.
On that composite Beyond Air ranks 142nd of 142 in the group, against a group median of -0.15.